<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="opa" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">opa</book-part-id>
      <title-group>
        <title>Optic Atrophy Type 1</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Delettre-Cribaillet</surname>
            <given-names>C&#x000e9;cile</given-names>
          </name>
          <degrees>PhD</degrees>
          <aff>Inserm U1051<break/>INM H&#x000f4;pital Saint Eloi<break/>Montpellier, France</aff>
          <email>cecile.delettre@inserm.fr</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Hamel</surname>
            <given-names>Christian P</given-names>
          </name>
          <degrees>MD</degrees>
          <aff>Inserm U1051<break/>INM H&#x000f4;pital Saint Eloi<break/>Montpellier, France</aff>
          <email>christian.hamel@inserm.fr</email>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Lenaers</surname>
            <given-names>Guy</given-names>
          </name>
          <degrees>PhD</degrees>
          <aff>UMR CNRS 6214<break/>Inserm U1083<break/>Centre Hospitalier Universitaire<break/>Angers, France</aff>
          <email>guy.lenaers@inserm.fr</email>
        </contrib>
      </contrib-group>
      <pub-history>
        <date date-type="created">
          <day>13</day>
          <month>7</month>
          <year>2007</year>
        </date>
        <date date-type="updated">
          <day>12</day>
          <month>11</month>
          <year>2015</year>
        </date>
        <date date-type="revised">
          <day>24</day>
          <month>3</month>
          <year>2009</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="opmd" document-type="chapter">Oculopharyngeal Muscular Dystrophy</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="ofd1" document-type="chapter">Oral-Facial-Digital Syndrome Type I</related-object>
      <abstract id="opa.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Optic atrophy type 1 (OPA1, or Kjer type optic atrophy) is characterized by bilateral and symmetric optic nerve pallor associated with insidious decrease in visual acuity (usually between ages 4 and 6 years), visual field defects, and color vision defects. Visual impairment is usually moderate (6/10 to 2/10), but ranges from mild or even insignificant to severe (legal blindness with acuity &#x0003c;1/20). The visual field defect is typically centrocecal, central, or paracentral; it is often large in those with severe disease. The color vision defect is often described as acquired blue-yellow loss (tritanopia). Other findings can include auditory neuropathy resulting in sensorineural hearing loss that ranges from severe and congenital to subclinical (i.e., identified by specific audiologic testing only).</p>
          <p>Visual evoked potentials are typically absent or delayed; pattern electroretinogram shows an abnormal N95:P50 ratio. Tritanopia is the classic feature of color vision defect, but more diffuse nonspecific dyschromatopsia is not uncommon. Ophthalmoscopic examination discloses temporal or diffuse pallor of the optic discs, sometimes associated with optic disc excavation. The neuroretinal rim shows some pallor in most cases, sometimes associated with a temporal pigmentary gray crescent.</p>
        </sec>
        <sec>
          <title>Diagnosis</title>
          <p>The diagnosis of OPA1 is made based on a combination of clinical findings, electrophysiologic studies, and family history and/or by the identification of a heterozygous pathogenic variant in <italic toggle="yes">OPA1</italic>, the only gene known to be associated with OPA1, by molecular genetic testing.</p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations:</italic> Low-vision aids for decreased visual acuity.</p>
          <p><italic toggle="yes">Surveillance:</italic> Annual ophthalmologic evaluations (including measurement of visual acuity, visual fields and optical coherence tomography) and hearing evaluations.</p>
          <p><italic toggle="yes">Agents/circumstances to avoid:</italic> Smoking, excessive alcohol intake, medications (antibiotics, antivirals) that interfere with mitochondrial metabolism.</p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>OPA1 is inherited in an autosomal dominant manner. Most individuals diagnosed with OPA1 have an affected parent; however, <italic toggle="yes">de novo</italic> pathogenic variants have been reported. Each child of an individual with OPA1 has a 50% chance of inheriting the pathogenic variant. Prenatal diagnosis for pregnancies at increased risk is possible if the pathogenic variant has been identified in an affected family member but genetic counseling remains complicated by the incomplete penetrance and the markedly variable inter- and intrafamilial expressivity of the disease.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="opa.Diagnosis">
        <title>Diagnosis</title>
        <sec id="opa.Suggestive_Findings">
          <title>Suggestive Findings</title>
          <p>Optic atrophy type 1 (OPA1 or Kjer type optic atrophy) <bold>should be suspected</bold> in individuals with the following clinical, electrophysiologic, and family history findings:</p>
          <p>
            <bold>Clinical findings</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Childhood onset</p>
            </list-item>
            <list-item>
              <p>Bilateral vision loss that is usually symmetric</p>
            </list-item>
            <list-item>
              <p>Visual field defect that is typically centrocecal, central, or paracentral</p>
            </list-item>
            <list-item>
              <p>Peripheral field that is usually normal, although inversion of red and blue isopters may occur.</p>
              <p>Note: The isopters are lines joining points of equal sensitivity on a visual field chart. The red isopter represents the largest/brightest stimulus; the blue isopter represents the smallest/dimmest stimulus. Persons with OPA1 have scotomas (areas of impaired visual acuity) in the central visual fields and sparing of the peripheral visual fields.</p>
            </list-item>
            <list-item>
              <p>Color vision defect, often described as acquired blue-yellow loss (tritanopia)</p>
            </list-item>
            <list-item>
              <p>Opthalmoscopic examination that demonstrates:</p>
              <list list-type="bullet">
                <list-item>
                  <p>Optic nerve pallor (the cardinal sign) that is most often bilateral and symmetric, but may be temporal (50% of individuals) and global (50%) [<xref ref-type="bibr" rid="opa.REF.votruba.2003.48">Votruba et al 2003</xref>];</p>
                </list-item>
                <list-item>
                  <p>Profound papillary excavation (21% of eyes with OPA1) [<xref ref-type="bibr" rid="opa.REF.alward.2003.2">Alward 2003</xref>];</p>
                </list-item>
                <list-item>
                  <p>Neuroretinal rim pallor in most cases, sometimes associated with a temporal pigmentary gray crescent.</p>
                </list-item>
              </list>
            </list-item>
          </list>
          <p>
            <bold>Electrophysiology</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Visual evoked potentials (VEPs) are typically absent or delayed, indicating a conduction defect in the optic nerve.</p>
            </list-item>
            <list-item>
              <p>Pattern electroretinogram (PERG) shows an abnormal N95:P50 ratio, with reduction in the amplitude of the N95 waveform [<xref ref-type="bibr" rid="opa.REF.holder.1998.217">Holder et al 1998</xref>]. Since the N95 component of the PERG is thought to be specific for the retinal ganglion cell, this finding supports a ganglion cell origin for the optic atrophy.</p>
              <p>Note: The PERG originates from the inner retinal layers, enabling an assessment of ganglion cell function, and is increasingly used in the assessment of anterior visual pathway dysfunction. The normal PERG consists of a prominent positive peak at 50 ms (P50), and a slow, broad trough with a minimum at 95 ms (N95). The positive P50 component is invariably affected in retinal and macular dysfunction, whereas the negative N95 component is principally affected in optic nerve disease. Furthermore, the ratio between N95 and P50 has been shown to be an effective measure of retinal ganglion cell function.</p>
            </list-item>
          </list>
          <p><bold>Family history</bold> consistent with autosomal dominant inheritance</p>
          <p>Note: Absence of a family history of OPA1 does not preclude the diagnosis.</p>
        </sec>
        <sec id="opa.Establishing_the_Diagnosis">
          <title>Establishing the Diagnosis</title>
          <p>The diagnosis of optic atrophy type 1 (OPA1) <bold>is established</bold> in a proband with the above clinical findings and/or a heterozygous pathogenic variant in <italic toggle="yes">OPA1</italic> by molecular genetic testing (see <xref ref-type="table" rid="opa.T.molecular_genetic_testing_used_in">Table 1</xref>).</p>
          <p>Molecular testing approaches can include <bold>single-gene testing</bold>, use of a <bold>multi-gene panel</bold>, and <bold>genomic testing</bold>.</p>
          <list list-type="bullet">
            <list-item>
              <p>
                <bold>Single-gene testing</bold>
              </p>
              <list list-type="bullet">
                <list-item>
                  <p>Targeted analysis for the <xref ref-type="table" rid="opa.T.opa1_pathogenic_variants_discussed">c.2826delT</xref> pathogenic variant can be performed first in individuals of Danish ancestry.</p>
                </list-item>
                <list-item>
                  <p>In individuals who are not of Danish ancestry or if targeted analysis does not identify a pathogenic variant, sequence analysis of <italic toggle="yes">OPA1</italic> is performed, followed by gene-targeted deletion/duplication analysis if no pathogenic variant is found.</p>
                </list-item>
                <list-item>
                  <p>If no pathogenic variant is identified, molecular genetic testing of <italic toggle="yes">OPA3</italic> for autosomal dominant optic atrophy type 3 (OPA3) and for the common mitochondrial DNA (mtDNA) single-nucleotide pathogenic variants responsible for <related-object link-type="booklink" source-id="gene" document-id="lhon" document-type="chapter">Leber hereditary optic neuropathy</related-object> (LHON) should be considered (see <xref ref-type="sec" rid="opa.Differential_Diagnosis">Differential Diagnosis</xref>).</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p><bold>A multi-gene panel</bold> that includes <italic toggle="yes">OPA1</italic> and other genes of interest (see <xref ref-type="sec" rid="opa.Differential_Diagnosis">Differential Diagnosis</xref>) may also be considered. Note: The genes included and sensitivity of multi-gene panels vary by laboratory and over time.</p>
            </list-item>
            <list-item>
              <p><bold>More comprehensive genomic testing</bold> (when available) including exome sequencing, genome sequencing, and mitochondrial sequencing may be considered if serial single-gene testing (and/or use of a multi-gene panel) fails to confirm a diagnosis in an individual with features of optic atrophy type 1. For more information on comprehensive genome sequencing click <related-object link-type="booklink" source-id="gene" document-id="app5" document-type="appendix" object-id="app5.Comprehensive_Genome_Sequencing" object-type="sec">here</related-object>.</p>
            </list-item>
          </list>
          <table-wrap id="opa.T.molecular_genetic_testing_used_in" orientation="portrait" position="anchor">
            <label>Table 1. </label>
            <caption>
              <p>Molecular Genetic Testing Used in Optic Atrophy Type 1</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_opa.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_opa.T.molecular_genetic_testing_used_in_1_1_1_1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_opa.T.molecular_genetic_testing_used_in_1_1_1_2" rowspan="2" valign="middle" align="left" scope="col" colspan="1" headers="hd_h_opa.T.molecular_genetic_testing_used_in_1_1_1_2">Test Method</th>
                  <th id="hd_h_opa.T.molecular_genetic_testing_used_in_1_1_1_3" valign="middle" colspan="2" align="left" scope="colgroup" rowspan="1">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by This Method</th>
                </tr>
                <tr>
                  <th headers="hd_h_opa.T.molecular_genetic_testing_used_in_1_1_1_3" id="hd_h_opa.T.molecular_genetic_testing_used_in_1_1_2_1" valign="middle" colspan="1" align="left" scope="colgroup" rowspan="1">Familial</th>
                  <th headers="hd_h_opa.T.molecular_genetic_testing_used_in_1_1_1_3" id="hd_h_opa.T.molecular_genetic_testing_used_in_1_1_2_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Simplex&#x000a0;<sup>3</sup></th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_opa.T.molecular_genetic_testing_used_in_1_1_1_1" rowspan="3" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">OPA1</italic>
                  </td>
                  <td headers="hd_h_opa.T.molecular_genetic_testing_used_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>4</sup></td>
                  <td headers="hd_h_opa.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_opa.T.molecular_genetic_testing_used_in_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">8/9&#x000a0;<sup>5</sup><break/>10/14&#x000a0;<sup>6</sup><break/>17/19&#x000a0;<sup>7</sup></td>
                  <td headers="hd_h_opa.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_opa.T.molecular_genetic_testing_used_in_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">4/8&#x000a0;<sup>5</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_opa.T.molecular_genetic_testing_used_in_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Gene-targeted deletion/duplication analysis&#x000a0;<sup>8</sup></td>
                  <td headers="hd_h_opa.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_opa.T.molecular_genetic_testing_used_in_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Unknown&#x000a0;<sup>9</sup></td>
                  <td headers="hd_h_opa.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_opa.T.molecular_genetic_testing_used_in_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Unknown</td>
                </tr>
                <tr>
                  <td headers="hd_h_opa.T.molecular_genetic_testing_used_in_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Targeted analysis for pathogenic variants&#x000a0;<sup>10</sup></td>
                  <td headers="hd_h_opa.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_opa.T.molecular_genetic_testing_used_in_1_1_2_1" valign="middle" align="left" rowspan="1" colspan="1">Unknown</td>
                  <td headers="hd_h_opa.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_opa.T.molecular_genetic_testing_used_in_1_1_2_2" valign="middle" align="left" rowspan="1" colspan="1">Unknown</td>
                </tr>
                <tr>
                  <td headers="hd_h_opa.T.molecular_genetic_testing_used_in_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">Unknown&#x000a0;<sup>11</sup></td>
                  <td headers="hd_h_opa.T.molecular_genetic_testing_used_in_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">NA</td>
                  <td headers="hd_h_opa.T.molecular_genetic_testing_used_in_1_1_1_3 hd_h_opa.T.molecular_genetic_testing_used_in_1_1_2_1 hd_h_opa.T.molecular_genetic_testing_used_in_1_1_2_2" valign="middle" colspan="2" align="left" rowspan="1"/>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="opa.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="opa" object-id="opa.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein name.</p>
              </fn>
              <fn id="opa.TF.1.2">
                <label>2. </label>
                <p>See <xref ref-type="sec" rid="opa.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants detected in this gene.</p>
              </fn>
              <fn id="opa.TF.1.3">
                <label>3. </label>
                <p>Simplex = a single occurrence in a family</p>
              </fn>
              <fn id="opa.TF.1.4">
                <label>4. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of uncertain significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exon or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="opa.TF.1.5">
                <label>5. </label>
                <p><xref ref-type="bibr" rid="opa.REF.nakamura.2006.483">Nakamura et al [2006]</xref> found heterozygous <italic toggle="yes">OPA1</italic> pathogenic variants in 8/9 familial cases and 4/8 simplex cases. Of note, on examination of family members of two apparently simplex cases, <xref ref-type="bibr" rid="opa.REF.nakamura.2006.483">Nakamura et al [2006]</xref> found heterozygous <italic toggle="yes">OPA1</italic> pathogenic variants in relatives with a normal or only mildly abnormal phenotype, supporting the notions of variable expressivity and reduced penetrance.</p>
              </fn>
              <fn id="opa.TF.1.6">
                <label>6. </label>
                <p>
                  <xref ref-type="bibr" rid="opa.REF.puomila.2005.337">Puomila et al [2005]</xref>
                </p>
              </fn>
              <fn id="opa.TF.1.7">
                <label>7. </label>
                <p>
                  <xref ref-type="bibr" rid="opa.REF.delettre.2001.584">Delettre et al [2001]</xref>
                </p>
              </fn>
              <fn id="opa.TF.1.8">
                <label>8. </label>
                <p>Gene-targeted deletion/duplication analysis detects intragenic deletions or duplications. Methods that may be used can include: quantitative PCR, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a gene-targeted microarray designed to detect single-exon deletions or duplications.</p>
              </fn>
              <fn id="opa.TF.1.9">
                <label>9. </label>
                <p>A ~325-bp intronic insertion resulting in exon skipping has been reported [<xref ref-type="bibr" rid="opa.REF.gallus.2010.178">Gallus et al 2010</xref>]. See <xref ref-type="sec" rid="opa.Molecular_Genetics">Molecular Genetics</xref>.</p>
              </fn>
              <fn id="opa.TF.1.10">
                <label>10. </label>
                <p>Detects the Danish founder pathogenic <xref ref-type="table" rid="opa.T.opa1_pathogenic_variants_discussed">c.2826delT</xref> variant. Note: Pathogenic variants included in a panel may vary by laboratory.</p>
              </fn>
              <fn id="opa.TF.1.11">
                <label>11. </label>
                <p>Because the detection rate for pathogenic variants in <italic toggle="yes">OPA1</italic> is less than 100%, it is possible that families in which a pathogenic variant is not detected are not linked to the <italic toggle="yes">OPA1</italic> locus; however, no evidence currently supports this possibility.</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
      </sec>
      <sec id="opa.Clinical_Characteristics">
        <title>Clinical Characteristics</title>
        <sec id="opa.Clinical_Description">
          <title>Clinical Description</title>
          <p><bold>Vision loss.</bold> OPA1 usually presents as insidious decrease in visual acuity between ages four and six years; in mild cases visual acuity may remain normal until early adult life. Visual acuity usually declines slowly with age. Although rare, rapid decline in visual acuity has been reported in adults [<xref ref-type="bibr" rid="opa.REF.kjer.1996.3">Kjer et al 1996</xref>].</p>
          <p>The visual impairment is usually moderate (6/10 to 2/10), but ranges from severe (legal blindness with acuity &#x0003c;1/20) to mild or even insignificant, and consequently can be underestimated.</p>
          <p>The vision loss is occasionally asymmetric.</p>
          <p>The visual field defect is typically centrocecal, central, or paracentral; it is often large in those with severe disease. The color vision defect is often described as acquired blue-yellow loss (tritanopia).</p>
          <p>Typical OPA1 is associated with a progressive and irreversible loss of vision. However, <xref ref-type="bibr" rid="opa.REF.cornille.2008.667">Cornille et al [2008]</xref> reported a man age 23 years who developed unexplained isolated, progressive, painless bilateral optic neuropathy as a result of central scotomas (visual acuity 20/200 in the right eye and 20/100 in the left eye) three months after the first signs of visual loss. Six months later he had spontaneous and durable partial recovery of visual acuity (20/30 in the right eye and 20/25 in the left eye). He was the first affected individual described with a heterozygous pathogenic variant in one of the three alternative <italic toggle="yes">OPA1</italic> exons (see <xref ref-type="sec" rid="opa.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</xref>).</p>
          <p><bold>Extra-ophthalmogic findings.</bold> Up to 10% of persons with a heterozgyous <italic toggle="yes">OPA1</italic> pathogenic variant have additional extra-ophthalmologic abnormalities, most commonly sensorineural hearing loss, ataxia, and myopathy, suggesting that pathogenic variants in <italic toggle="yes">OPA1</italic> may be responsible for a continuum of phenotypes ranging from mild disorders affecting only the retinal ganglion cells to a severe and multisystemic disease.</p>
          <p><bold>Sensorineural hearing loss</bold> that ranges from severe and congenital to subclinical (requiring specific testing for detection) is the most frequently extra-ocular feature observed. Such hearing loss appears to be due to auditory neuropathy [<xref ref-type="bibr" rid="opa.REF.amatibonneau.2005.958">Amati-Bonneau et al 2005</xref>]. Seven pathogenic variants in <italic toggle="yes">OPA1</italic> have been found to be associated with optic atrophy and hearing loss (see <xref ref-type="sec" rid="opa.GenotypePhenotype_Correlations">Genotype-Phenotype Correlations</xref>). Both intra- and interfamilial variation in the presence of hearing loss with optic atrophy has been observed.</p>
          <p><bold>Ataxia</bold> and <bold>myopathy.</bold> Some individuals developed proximal myopathy (35%), a combination of cerebellar and sensory ataxia in adulthood (29%), and axonal sensory and/or motor neuropathy (29%). These features became manifest from the third decade of life onwards.</p>
          <p>Muscle biopsy revealed features diagnostic of mitochondrial myopathy. In these individuals approximately 10% of all fibers were deficient in histochemical COX activity and several fibers showed evidence of subsarcolemmal accumulation of abnormal mitochondria.</p>
          <p>
            <bold>Pathology</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The cardinal sign of OPA1 is optic atrophy that appears as bilateral and generally symmetric temporal pallor of the optic disc, implying the loss of central retinal ganglion cells.</p>
            </list-item>
            <list-item>
              <p>Histopathology shows a normal outer retina and loss of retinal ganglion cells, primarily in the macula and in the papillo-macular bundle of the optic nerve.</p>
            </list-item>
          </list>
        </sec>
        <sec id="opa.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>No correlation has been observed between the degree of visual impairment and the location or type of pathogenic variant [<xref ref-type="bibr" rid="opa.REF.puomila.2005.337">Puomila et al 2005</xref>].</p>
          <p>Complete deletion of <italic toggle="yes">OPA1</italic> results in typical dominant optic atrophy without predictable severity or other deficits [<xref ref-type="bibr" rid="opa.REF.marchbank.2002.e47">Marchbank et al 2002</xref>]. However, it appears that pathogenic in-frame deletions involve loss of visual acuity (1/10 on average) that is statistically slightly more severe than that resulting from pathogenic truncating variants or pathogenic missense substitutions (2/10 on average) [Ait Ali et al, unpublished].</p>
          <p><bold>Optic atrophy</bold> and <bold>hearing loss.</bold> Seven different pathogenic variants in <italic toggle="yes">OPA1</italic> have been reported in individuals with both optic atrophy and hearing loss: <xref ref-type="table" rid="opa.T.opa1_pathogenic_variants_discussed">p.Arg445His</xref>, <xref ref-type="table" rid="opa.T.opa1_pathogenic_variants_discussed">p.Gly401Asp</xref>, <xref ref-type="table" rid="opa.T.opa1_pathogenic_variants_discussed">p.Leu243Ter</xref>, <xref ref-type="table" rid="opa.T.opa1_pathogenic_variants_discussed">c.983A&#x0003e;G</xref>, <xref ref-type="table" rid="opa.T.opa1_pathogenic_variants_discussed">p.Ile463_Phe464dup</xref>, <xref ref-type="table" rid="opa.T.opa1_pathogenic_variants_discussed">p.Gln437Arg</xref>, and <xref ref-type="table" rid="opa.T.opa1_pathogenic_variants_discussed">p.Ala357LeufsTer4</xref> [<xref ref-type="bibr" rid="opa.REF.leruez.2013.e236">Leruez et al 2013</xref>].</p>
          <list list-type="bullet">
            <list-item>
              <p>In an individual with the <xref ref-type="table" rid="opa.T.opa1_pathogenic_variants_discussed">p.Arg445His</xref> pathogenic variant, auditory brain stem responses (ABRs) were absent and both ears had normal evoked otoacoustic emissions [<xref ref-type="bibr" rid="opa.REF.amatibonneau.2005.958">Amati-Bonneau et al 2005</xref>]. Because evoked otoacoustic emissions reflect the functional state of presynaptic elements (the outer hair cells), and the ABRs reflect the integrity of the auditory pathway from the auditory nerve to the inferior colliculus, the presence of evoked otoacoustic emissions and the lack of ABRs support the diagnosis of auditory neuropathy.</p>
            </list-item>
            <list-item>
              <p><xref ref-type="bibr" rid="opa.REF.treft.1984.908">Treft et al [1984]</xref> and <xref ref-type="bibr" rid="opa.REF.meire.1985.91">Meire et al [1985]</xref> reported two unrelated families with autosomal dominant optic atrophy, hearing loss, ptosis, and ophthalmoplegia. Subsequent studies revealed the <xref ref-type="table" rid="opa.T.opa1_pathogenic_variants_discussed">p.Arg445His</xref> pathogenic variant in <italic toggle="yes">OPA1</italic> in both families [<xref ref-type="bibr" rid="opa.REF.payne.2004.749">Payne et al 2004</xref>].</p>
            </list-item>
            <list-item>
              <p><xref ref-type="bibr" rid="opa.REF.li.2005.208">Li et al [2005]</xref> identified the <xref ref-type="table" rid="opa.T.opa1_pathogenic_variants_discussed">p.Arg445His</xref> pathogenic variant in a family with optic atrophy and hearing loss, without ptosis or ocular motility abnormalities. These family members are also myopic, but it is not clear whether myopia is part of the phenotype.</p>
            </list-item>
            <list-item>
              <p>In contrast, the <xref ref-type="table" rid="opa.T.opa1_pathogenic_variants_discussed">p.Arg445His</xref> pathogenic variant was associated with optic atrophy <bold>without</bold> hearing loss in a Japanese individual age 21 years; no other family member was clinically affected or had the <italic toggle="yes">OPA1</italic> pathogenic variant [<xref ref-type="bibr" rid="opa.REF.shimizu.2003.256">Shimizu et al 2003</xref>].</p>
            </list-item>
          </list>
          <p><bold>Alternate <italic toggle="yes">OPA1</italic> transcripts.</bold>
<xref ref-type="bibr" rid="opa.REF.cornille.2008.667">Cornille et al [2008]</xref> reported a young man with unexplained isolated, progressive, painless bilateral optic neuropathy as a result of central scotomas (see <xref ref-type="sec" rid="opa.Clinical_Description">Clinical Description</xref>, <bold>Visual loss</bold>) who harbored a heterozygous pathogenic variant in exon 5b (<xref ref-type="table" rid="opa.T.opa1_pathogenic_variants_discussed">c.740G&#x0003e;A</xref>). This was the first report of a pathogenic variant in one of the three alternative <italic toggle="yes">OPA1</italic> exons, leading to an amino acid change in the N-terminal coiled coil domain (<xref ref-type="table" rid="opa.T.opa1_pathogenic_variants_discussed">p.Arg247His</xref>) from isoform 8. This individual had spontaneous and durable partial recovery of visual acuity (20/30 in the right eye and 20/25 in the left eye) six months later.</p>
        </sec>
        <sec id="opa.Penetrance">
          <title>Penetrance</title>
          <p>The estimated penetrance of 98% in OPA1 has been revised in the light of molecular genetic studies. Penetrance varies from family to family and pathogenic variant to pathogenic variant. It has been reported as high as 100% (variant <xref ref-type="table" rid="opa.T.opa1_pathogenic_variants_discussed">c.1065+1G&#x0003e;T</xref>, resulting in exon 12 skipping) [<xref ref-type="bibr" rid="opa.REF.thiselton.2002.1715">Thiselton et al 2002</xref>] and as low as 43% (variant <xref ref-type="table" rid="opa.T.opa1_pathogenic_variants_discussed">c.2708_2711delTTAG</xref> in exon 27) [<xref ref-type="bibr" rid="opa.REF.toomes.2001.1369">Toomes et al 2001</xref>]. In these two studies the clinical diagnosis was made on the basis of reduced visual acuity, abnormal color discrimination, fundus examination showing temporal pallor of the optic disc, and electrophysiology studies [<xref ref-type="bibr" rid="opa.REF.toomes.2001.1369">Toomes et al 2001</xref>, <xref ref-type="bibr" rid="opa.REF.thiselton.2002.1715">Thiselton et al 2002</xref>].</p>
        </sec>
        <sec id="opa.Nomenclature">
          <title>Nomenclature</title>
          <p>Optic atrophy type 1 was formerly known as Kjer type optic atrophy.</p>
        </sec>
        <sec id="opa.Prevalence">
          <title>Prevalence</title>
          <p>OPA1 is believed to be the most common of the hereditary optic neuropathies.</p>
          <p>The estimated prevalence of OPA1 is 1:50,000 in most populations, or as high as 1:10,000 in Denmark. The relatively high frequency of OPA1 in Denmark may be attributable to a founder effect [<xref ref-type="bibr" rid="opa.REF.thiselton.2002.1715">Thiselton et al 2002</xref>].</p>
        </sec>
      </sec>
      <sec id="opa.Genetically_Related_Allelic_Disorder">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No phenotypes other than those discussed in this <italic toggle="yes">GeneReview</italic> are known to be associated with pathogenic variants in <italic toggle="yes">OPA1</italic>.</p>
      </sec>
      <sec id="opa.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p><bold><italic toggle="yes">OPA3.</italic></bold>
<italic toggle="yes">OPA3</italic> consists of three exons and encodes for an inner mitochondrial membrane protein. The function of this protein is not well known. Two disorders are associated with pathogenic variants in <italic toggle="yes">OPA3</italic>:</p>
        <list list-type="bullet">
          <list-item>
            <p><related-object link-type="booklink" source-id="gene" document-id="mga3" document-type="chapter"><bold>Costeff optic atrophy syndrome</bold></related-object>
<bold>(3-methylglutaconic aciduria type 3).</bold> Pathogenic truncating variants are responsible for this neuroophthalmologic syndrome consisting of early-onset bilateral optic atrophy and later-onset spasticity, extrapyramidal dysfunction, and cognitive deficit. Urinary excretion of 3-methylglutaconic acid and of 3-methglutaric acid is increased. Inheritance is autosomal recessive.</p>
          </list-item>
          <list-item>
            <p><bold>Autosomal optic atrophy and cataract (ADOAC, OPA3)</bold> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/165300">OMIM</ext-link>). <xref ref-type="bibr" rid="opa.REF.reynier.2004.e110">Reynier et al [2004]</xref> have identified two pathogenic variants in <italic toggle="yes">OPA3</italic> (p.Gly93Ser and p.Gln105Glu) that change one of the amino acids. Inheritance is autosomal dominant.</p>
          </list-item>
        </list>
        <p><related-object link-type="booklink" source-id="gene" document-id="lhon" document-type="chapter"><bold>Leber hereditary optic neuropathy</bold></related-object>
<bold>(LHON)</bold> is the major differential diagnosis for optic atrophy type 1 (OPA1). LHON typically presents in young adults as painless subacute bilateral visual failure. Males are more commonly affected than females. Women tend to develop the disorder slightly later in life and may be more severely affected. The acute phase begins with blurring of central vision and color desaturation that affect both eyes simultaneously in up to 25% of cases. After the initial symptoms, both eyes are usually affected within six months. The central visual acuity deteriorates to the level of counting fingers in the majority of cases. After the acute phase, the optic discs become atrophic. Significant improvements in visual acuity are rare. Individuals then proceed into the atrophic phase and are usually legally blind for the rest of their lives with a permanent large centrocecal scotoma. Neurologic abnormalities such as postural tremor, peripheral neuropathy, nonspecific myopathy, and movement disorders have been reported to be more common in individuals with LHON than in controls. Some individuals with LHON, usually women, also have a multiple sclerosis (MS)-like illness.</p>
        <p>LHON is transmitted by maternal inheritance. In one large study, 90% of individuals with LHON were found to have one of three pathogenic variants in mtDNA: m.11778G&#x0003e;A, m.14484T&#x0003e;C, m.3460G&#x0003e;A.</p>
        <p><bold>Autosomal dominant optic atrophy (ADOA).</bold> Two other loci associated with autosomal dominant optic atrophy have been identified:</p>
        <list list-type="bullet">
          <list-item>
            <p>OPA4 (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.omim.org/entry/605293">OMIM</ext-link>) was mapped to 8q12.2-q12.3 in a single large family by <xref ref-type="bibr" rid="opa.REF.kerrison.1999.805">Kerrison et al [1999]</xref>; however, the locus has not been confirmed and the gene in which mutation is causative is unknown.</p>
          </list-item>
          <list-item>
            <p>OPA5 (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/610708">OMIM</ext-link>) was mapped to 22q12.1-q13.1 by <xref ref-type="bibr" rid="opa.REF.barbet.2005.e1">Barbet et al [2005]</xref> in two unrelated families.</p>
          </list-item>
        </list>
        <p>The phenotype of the three families with OPA4 or OPA5 is comparable to the phenotype seen in OPA1: optic nerve pallor, decreased visual acuity, color vision defects, impaired VEP, and normal ERG. No extraocular findings were described in these families.</p>
        <p>Another OPA locus for autosomal dominant optic atrophy (OPA8) was mapped to 16q21-q22 in one Italian family with extraophthalmologic features extending to the auditory system [<xref ref-type="bibr" rid="opa.REF.carelli.2007.a42">Carelli et al 2007</xref>]. The gene in which mutation is causative is unknown.</p>
        <p><related-object link-type="booklink" source-id="gene" document-id="ddon" document-type="chapter"><bold>Deafness-dystonia-optic neuronopathy syndrome</bold></related-object>
<bold>(DDON).</bold> Males with DDON have prelingual or postlingual sensorineural hearing impairment in early childhood, slowly progressive dystonia or ataxia in the teens, slowly progressive decreased visual acuity from optic atrophy beginning about age 20 years, and dementia beginning at about age 40 years. Psychiatric symptoms such as personality change and paranoia may appear in childhood and progress. The hearing impairment phenotype is a progressive auditory neuropathy, while the neurologic, visual, and neuropsychiatric signs vary in degree of severity and rate of progression. Females may have mild hearing impairment and focal dystonia.</p>
        <p>Inheritance is X-linked. The DDON syndrome occurs as either a single-gene disorder resulting from pathogenic variants in <italic toggle="yes">TIMM8A</italic> or a contiguous gene deletion syndrome at Xq22, which also includes <related-object link-type="booklink" source-id="gene" document-id="xla" document-type="chapter">X-linked agammaglobulinemia</related-object> caused by disruption of <italic toggle="yes">BTK</italic>, located telomeric to <italic toggle="yes">TIMM8A</italic>.</p>
        <p><bold><italic toggle="yes">WFS1</italic>.</bold> Biallelic pathogenic variants in <italic toggle="yes">WFS1</italic> are generally associated with optic atrophy (OPA) as part of the autosomal recessive Wolfram syndrome phenotype (DIDMOAD [<italic toggle="yes">d</italic>iabetes <italic toggle="yes">i</italic>nsipidus, <italic toggle="yes">d</italic>iabetes <italic toggle="yes">m</italic>ellitus, <italic toggle="yes">o</italic>ptic <italic toggle="yes">a</italic>trophy, <italic toggle="yes">d</italic>eafness]). Heterozygous pathogenic variants in <italic toggle="yes">WFS1</italic> cause autosomal dominant progressive low-frequency sensorineural hearing loss (LFSNHL) without ophthalmologic abnormalities [<xref ref-type="bibr" rid="opa.REF.cryns.2003.275">Cryns et al 2003</xref>]. However, <xref ref-type="bibr" rid="opa.REF.eiberg.2006.435">Eiberg et al [2006]</xref> identified a <italic toggle="yes">WFS1</italic> heterozygous pathogenic variant associated with autosomal dominant optic atrophy, hearing loss, and impaired glucose regulation in one family, supporting the notion that heterozygous pathogenic variants in <italic toggle="yes">WFS1</italic> as well as in <italic toggle="yes">OPA1</italic> may lead to optic atrophy combined with hearing impairment (see <related-object link-type="booklink" source-id="gene" document-id="wfs" document-type="chapter"><italic toggle="yes">WFS1</italic>-Related Disorders</related-object>).</p>
        <p><bold><italic toggle="yes">MFN2</italic>.</bold>
<related-object link-type="booklink" source-id="gene" document-id="cmt2a" document-type="chapter">Charcot-Marie-Tooth (CMT) neuropathy type 2A</related-object> with visual impairment resulting from optic atrophy has been designated as hereditary motor and sensory neuropathy type VI (HMSN VI) [<xref ref-type="bibr" rid="opa.REF.voo.2003.670">Voo et al 2003</xref>]. <xref ref-type="bibr" rid="opa.REF.z_chner.2006.276">Z&#x000fc;chner et al [2006]</xref> described six families with HMSN VI with a subacute onset of optic atrophy and subsequent slow recovery of visual acuity in 60% of affected individuals. In each pedigree a unique heterozygous pathogenic variant in <italic toggle="yes">MFN2</italic>, encoding mitofusin 2, was identified. Inheritance is autosomal dominant.</p>
        <p><bold>Other optic neuropathies.</bold> The acquired blue-yellow loss (tritanopia) helps differentiate OPA1 from other optic neuropathies in which the axis of confusion is red-green:</p>
        <list list-type="bullet">
          <list-item>
            <p><bold>OPA2</bold> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/311050">OMIM</ext-link>). A gene for X-linked optic atrophy (OPA2) has been mapped to chromosome Xp11.4-p11.21; to date no gene has been identified.</p>
          </list-item>
          <list-item>
            <p><bold>OPA6</bold> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/258500">OMIM</ext-link>). The first locus for isolated autosomal recessive optic atrophy (ROA1) has been mapped to chromosome 8q. Dyschromatopsia for red-green confusion occurs in OPA6.</p>
          </list-item>
          <list-item>
            <p><bold>OPA7</bold> (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/entry/612989">OMIM</ext-link>). <xref ref-type="bibr" rid="opa.REF.hanein.2009.493">Hanein et al [2009]</xref> identified an autosomal recessive juvenile-onset optic atrophy in a large multiplex consanguineous Algerian family and subsequently in three other Maghreb families. This form of optic atrophy is caused by biallelic pathogenic variants in <italic toggle="yes">TMEM126A</italic>, which encodes a mitochondrial protein found in higher eukaryotes that has four transmembrane domains and a central domain conserved with the related protein encoded by <italic toggle="yes">TMEM126B</italic>.</p>
          </list-item>
        </list>
        <p><bold>Acquired optic neuropathy</bold> can be caused by the following:</p>
        <list list-type="bullet">
          <list-item>
            <p>Nutritional deficiencies of protein, or of the B vitamins and folate, associated with starvation, malabsorption, or alcoholism</p>
          </list-item>
          <list-item>
            <p>Toxic exposures. The most common is "tobacco-alcohol amblyopia," thought to be caused by exposure to cyanide from tobacco smoking, and by low levels of vitamin B<sub>12</sub> caused by poor nutrition and poor absorption associated with drinking alcohol. Other possible toxins include ethambutol, methyl alcohol, ethylene glycol, cyanide, lead, and carbon monoxide.</p>
          </list-item>
          <list-item>
            <p>Certain medications</p>
          </list-item>
        </list>
        <p>See <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://omim.org/phenotypicSeries/PS165500">Optic atrophy: OMIM Phenotypic Series</ext-link> to view genes associated with this phenotype in OMIM.</p>
      </sec>
      <sec id="opa.Management">
        <title>Management</title>
        <sec id="opa.Evaluations_Following_Initial_Diagno">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease and needs in an individual with optic atrophy type 1 (OPA1), the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Assessment of visual acuity, color vision, and visual fields</p>
            </list-item>
            <list-item>
              <p>Assessment of extraocular muscles (the affected individual is asked to follow the ophthalmoscope with his/her eyes without moving the head)</p>
            </list-item>
            <list-item>
              <p>Hearing evaluation: auditory brain stem responses (ABRs), auditory evoked potentials (AEPs), and evoked otoacoustic emissions</p>
            </list-item>
            <list-item>
              <p>Oral glucose tolerance test</p>
            </list-item>
            <list-item>
              <p>Consultation with a clinical geneticist and/or genetic counselor</p>
            </list-item>
          </list>
        </sec>
        <sec id="opa.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>No treatment for OPA1 is of proven efficacy.</p>
          <p>Treatment of decreased visual acuity is symptomatic (e.g., low-vision aids).</p>
          <p>For treatment of sensorineural hearing loss, see <related-object link-type="booklink" source-id="gene" document-id="deafness-overview" document-type="chapter">Deafness and Hereditary Hearing Loss Overview</related-object>.</p>
          <p>For treatment of ataxia, see <related-object link-type="booklink" source-id="gene" document-id="ataxias" document-type="chapter">Ataxia Overview</related-object>.</p>
        </sec>
        <sec id="opa.Surveillance">
          <title>Surveillance</title>
          <p>Appropriate surveillance includes:</p>
          <list list-type="bullet">
            <list-item>
              <p>Annual ophthalmologic examination, including measurement of visual acuity and visual fields and optical coherence tomography (OCT);</p>
            </list-item>
            <list-item>
              <p>Annual hearing evaluation.</p>
            </list-item>
          </list>
        </sec>
        <sec id="opa.AgentsCircumstances_to_Avoid">
          <title>Agents/Circumstances to Avoid</title>
          <p>Individuals with an <italic toggle="yes">OPA1</italic> pathogenic variant are advised:</p>
          <list list-type="bullet">
            <list-item>
              <p>Not to smoke;</p>
            </list-item>
            <list-item>
              <p>To moderate their alcohol intake;</p>
            </list-item>
            <list-item>
              <p>To use sunglasses to limit UV exposure;</p>
              <p>Note: While limiting UV exposure is a good practice, no evidence for its effectiveness exists.</p>
            </list-item>
            <list-item>
              <p>To avoid medications (antibiotics, antivirals) that interfere with mitochondrial metabolism.</p>
            </list-item>
          </list>
        </sec>
        <sec id="opa.Evaluation_of_Relatives_at_Risk">
          <title>Evaluation of Relatives at Risk</title>
          <p>See <xref ref-type="sec" rid="opa.Related_Genetic_Counseling_Issues">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="opa.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>A study using the antioxidant EPI-743 in individuals with autosomal dominant optic atrophy (ADOA), including persons with OPA1, is in preparation in Italy (Dr. Valerio Carelli, University of Bologna).</p>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p>
        </sec>
      </sec>
      <sec id="opa.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="opa.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Optic atrophy type 1 (OPA1) is inherited in an autosomal dominant manner.</p>
        </sec>
        <sec id="opa.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p>
            <bold>Parents of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>Most individuals diagnosed with OPA1 have an affected parent.</p>
            </list-item>
            <list-item>
              <p>A proband with OPA1 may have the disorder as the result of a <italic toggle="yes">de novo OPA1</italic> pathogenic variant.</p>
              <list list-type="bullet">
                <list-item>
                  <p>Two instances of <italic toggle="yes">de novo</italic> pathogenic variants have been reported [<xref ref-type="bibr" rid="opa.REF.baris.2003.656">Baris et al 2003</xref>].</p>
                </list-item>
                <list-item>
                  <p>In a report of molecular genetic testing in 980 persons for suspected hereditary optic neuropathies, about half of those identified as having a heterozygous <italic toggle="yes">OPA1</italic> pathogenic variant were simplex cases (i.e., a single occurrence in a family) [<xref ref-type="bibr" rid="opa.REF.ferr_.2009.e692">Ferr&#x000e9; et al 2009</xref>].</p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p>If the pathogenic variant found in the proband cannot be detected in leukocyte DNA of either parent, two possible explanations are <italic toggle="yes">de novo</italic> mutation in the proband or germline mosaicism in a parent. Although no instances of germline mosaicism have been reported, it remains a possibility.</p>
            </list-item>
            <list-item>
              <p>Recommendations for the evaluation of parents of a proband with an apparent <italic toggle="yes">de novo</italic> pathogenic variant include: (1) ophthalmologic evaluation including an assessment of visual acuity, color vision, and visual fields; and (2) audiologic examinations consisting of auditory brain stem responses (ABRs), auditory evoked potentials (AEP) recordings, and study of evoked otoacoustic emissions.</p>
            </list-item>
            <list-item>
              <p>The family history of some individuals diagnosed with OPA1 may appear to be negative because of failure to recognize the disorder in family members, reduced penetrance, early death of the parent before the onset of symptoms, or late onset of the disorder in the affected parent. Therefore, an apparently negative family history cannot be confirmed unless appropriate clinical evaluation and/or molecular genetic testing has been performed on the parents of the proband.</p>
            </list-item>
          </list>
          <p>
            <bold>Sibs of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to the sibs of the proband depends on the genetic status of the proband's parents.</p>
            </list-item>
            <list-item>
              <p>If a parent of the proband is affected, the risk to the sibs is 50%.</p>
            </list-item>
            <list-item>
              <p>When the parents are found on the basis of visual acuity study, color vision evaluation, fundus examination, VEP, and PERG to be clinically unaffected, the risk to the sibs of a proband appears to be low.</p>
            </list-item>
            <list-item>
              <p>The sibs of a proband with clinically unaffected parents are still at increased risk for OPA1 because of the possibility of reduced penetrance in a parent.</p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Each child of an individual with OPA1 is at a 50% risk of inheriting the <italic toggle="yes">OPA1</italic> pathogenic variant.</p>
          <p>
            <bold>Other family members of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to other family members depends on the status of the proband's parents.</p>
            </list-item>
            <list-item>
              <p>If a parent is affected or has an <italic toggle="yes">OPA1</italic> pathogenic variant, his or her family members are at risk.</p>
            </list-item>
          </list>
        </sec>
        <sec id="opa.Related_Genetic_Counseling_Issues">
          <title>Related Genetic Counseling Issues</title>
          <p><bold>Considerations in families with an apparent <italic toggle="yes">de novo</italic> pathogenic variant.</bold> When neither parent of a proband with optic atrophy type 1 has the <italic toggle="yes">OPA1</italic> pathogenic variant or clinical evidence of the disorder based on visual acuity study, color vision evaluation, fundus examination, VEP, and PERG, the <italic toggle="yes">OPA1</italic> pathogenic variant is likely <italic toggle="yes">de novo</italic>. However, possible non-medical explanations including alternate paternity or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored.</p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected or at risk.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals.</p>
        </sec>
        <sec id="opa.Prenatal_Testing_and_Preimplantation">
          <title>Prenatal Testing and Preimplantation Genetic Diagnosis</title>
          <p>Once the <italic toggle="yes">OPA1</italic> pathogenic variant has been identified in an affected family member, prenatal testing for a pregnancy at increased risk and preimplantation genetic diagnosis for OPA1 are possible.</p>
          <p>Requests for prenatal testing for conditions which (like OPA1) do not affect intellect or life span are not common. Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although most centers would consider decisions about prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p>
        </sec>
      </sec>
      <sec id="opa.Resources">
        <title>Resources</title>
      </sec>
      <sec id="opa.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <sec id="opa.Molecular_Genetic_Pathogenesis">
          <title>Molecular Genetic Pathogenesis</title>
          <p>Because <italic toggle="yes">OPA1</italic> expression is ubiquitous, and it was recently proposed that neither the pattern nor the abundance of <italic toggle="yes">OPA1</italic> mRNA and dynamin-like 120-kd protein variants are specific to retinal ganglion cell (RGC) [<xref ref-type="bibr" rid="opa.REF.kamei.2005.4288">Kamei et al 2005</xref>], a plausible hypothesis as to why these neurons may be more vulnerable to <italic toggle="yes">OPA1</italic> inactivation could be a particular susceptibility to mitochondrial membrane disorders inducing mitochondrial dysfunction or mislocalization. While the former point is in agreement with reports that describe altered mitochondrial ATP synthesis and respiration in <italic toggle="yes">OPA1</italic>-inactivated cells [<xref ref-type="bibr" rid="opa.REF.lodi.2004.719">Lodi et al 2004</xref>, <xref ref-type="bibr" rid="opa.REF.amatibonneau.2005.958">Amati-Bonneau et al 2005</xref>, <xref ref-type="bibr" rid="opa.REF.chen.2005.26185">Chen et al 2005</xref>], the latter may relate to the particular distribution of the mitochondria in retinal ganglion cells. These show an accumulation of mitochondria in the cell bodies and in the intraretinal unmyelinated axons, where they accumulate in the varicosities, and a relative paucity of mitochondria in the myelinated parts of axons [<xref ref-type="bibr" rid="opa.REF.andrews.1999.231">Andrews et al 1999</xref>, <xref ref-type="bibr" rid="opa.REF.bristow.2002.791">Bristow et al 2002</xref>, <xref ref-type="bibr" rid="opa.REF.wang.2003.2">Wang et al 2003</xref>]. Furthermore, the effect of mitochondrial dynamics on the correct intracellular distribution of the mitochondria and its influence on neuronal plasticity and function was recently highlighted by inactivation of <italic toggle="yes">DRP1</italic> in live hippocampal neurons [<xref ref-type="bibr" rid="opa.REF.li.2004.873">Li et al 2004</xref>]. A link between axonal transport of mitochondria [<xref ref-type="bibr" rid="opa.REF.hollenbeck.2005.5411">Hollenbeck &#x00026; Saxton 2005</xref>] and mitochondrial dynamics was also enlightened by a recent study showing that <italic toggle="yes">Drosophila</italic> mutants lacking the ortholog of human DRP1 protein failed to populate the distal axon with mitochondria, affecting the mobilization of the synaptic vesicle reserve pool [<xref ref-type="bibr" rid="opa.REF.hollenbeck.2005.331">Hollenbeck 2005</xref>]. Moreover, pathogenic variants in the pro-fusion protein encoded by <italic toggle="yes">MFN2</italic>, which cause a peripheral neuropathy (see <related-object link-type="booklink" source-id="gene" document-id="cmt2a" document-type="chapter">CMT2A</related-object>) [<xref ref-type="bibr" rid="opa.REF.z_chner.2006.276">Z&#x000fc;chner et al 2006</xref>], significantly impaired the transport of mitochondria in axons in neurons expressing disease-causing forms of <italic toggle="yes">MFN2</italic> [<xref ref-type="bibr" rid="opa.REF.baloh.2007.422">Baloh et al 2007</xref>]. These data suggest that proper localization of mitochondria is critical for axonal and synaptic function.</p>
          <p><bold>Gene structure.</bold>
<italic toggle="yes">OPA1</italic> consists of 31 exons spanning more than 114 kb of genomic DNA. Eight isoforms have been described as a result of alternative splicing of exons 4, 4b, and 5b [<xref ref-type="bibr" rid="opa.REF.delettre.2001.584">Delettre et al 2001</xref>]. For details see <related-object source-id="gene" document-id="opa" object-id="opa.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
          <p><bold>Pathogenic variants.</bold> There is a wide spectrum of pathogenic variants, with more than 213 reported to date (see <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://mitodyn.org/home.php?select_db=OPA1">eOPA1</ext-link>, an online database for <italic toggle="yes">OPA1</italic> pathogenic variants) [<xref ref-type="bibr" rid="opa.REF.ferr_.2015.20">Ferr&#x000e9; et al 2015</xref>]. The <italic toggle="yes">OPA1</italic> pathogenic variants are distributed throughout the coding sequence, but most are localized in exons 8-16 encoding the GTPase domain and in the last two coding exons: 27 and 28); fewer pathogenic variants are found in exons 1 to 7. To date no pathogenic variants have been found in exons 4 and 4b, which are alternatively spliced. See <related-object source-id="gene" document-id="opa" object-id="opa.molgen.TA">Table A</related-object>. However, a heterozygous pathogenic variant in exon 5b (c.740G&#x0003e;A) has been described in one affected individual [<xref ref-type="bibr" rid="opa.REF.cornille.2008.667">Cornille et al 2008</xref>].</p>
          <p>An ~325-bp Alu-element insertion located in intron 7 of <italic toggle="yes">OPA1</italic> [<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/224831242">NM_015560.2</ext-link>] has been described as causing an in-frame deletion of exon 8 in a family with autosomal dominant optic atrophy (ADOA) [<xref ref-type="bibr" rid="opa.REF.gallus.2010.178">Gallus et al 2010</xref>].</p>
          <table-wrap id="opa.T.opa1_pathogenic_variants_discussed" orientation="portrait" position="anchor">
            <label>Table 2. </label>
            <caption>
              <p><italic toggle="yes">OPA1</italic> Pathogenic Variants Discussed in This <italic toggle="yes">GeneReview</italic></p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_opa.T.opa1_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">DNA Nucleotide Change <break/>(Alias&#x000a0;<sup>1</sup>)</th>
                  <th id="hd_h_opa.T.opa1_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Predicted Protein Change</th>
                  <th id="hd_h_opa.T.opa1_pathogenic_variants_discussed_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Reference Sequences</th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_opa.T.opa1_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.740G&#x0003e;A&#x000a0;<sup>2</sup></td>
                  <td headers="hd_h_opa.T.opa1_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg247His</td>
                  <td headers="hd_h_opa.T.opa1_pathogenic_variants_discussed_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/NM_130837.2">NM_130837.2</ext-link><break/><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/NP_570850.2">NP_570850.2</ext-link> (isoform 8)</td>
                </tr>
                <tr>
                  <td headers="hd_h_opa.T.opa1_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1065+1G&#x0003e;T<break/>(IVS12+1G&#x0003e;T)</td>
                  <td headers="hd_h_opa.T.opa1_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">--</td>
                  <td headers="hd_h_opa.T.opa1_pathogenic_variants_discussed_1_1_1_3" rowspan="10" valign="middle" align="left" colspan="1"><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/nuccore/224831242">NM_015560.2</ext-link><break/><ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/protein/224831243">NP_056375.2</ext-link> (isoform 1)</td>
                </tr>
                <tr>
                  <td headers="hd_h_opa.T.opa1_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.728T&#x0003e;A</td>
                  <td headers="hd_h_opa.T.opa1_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Leu243Ter</td>
                </tr>
                <tr>
                  <td headers="hd_h_opa.T.opa1_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.983A&#x0003e;G&#x000a0;<sup>3</sup></td>
                  <td headers="hd_h_opa.T.opa1_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">--</td>
                </tr>
                <tr>
                  <td headers="hd_h_opa.T.opa1_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1067_1068dup</td>
                  <td headers="hd_h_opa.T.opa1_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Ala357LeufsTer4</td>
                </tr>
                <tr>
                  <td headers="hd_h_opa.T.opa1_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1202G&#x0003e;A</td>
                  <td headers="hd_h_opa.T.opa1_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gly401Asp</td>
                </tr>
                <tr>
                  <td headers="hd_h_opa.T.opa1_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1310A&#x0003e;G</td>
                  <td headers="hd_h_opa.T.opa1_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Gln437Arg</td>
                </tr>
                <tr>
                  <td headers="hd_h_opa.T.opa1_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1334G&#x0003e;A</td>
                  <td headers="hd_h_opa.T.opa1_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg445His</td>
                </tr>
                <tr>
                  <td headers="hd_h_opa.T.opa1_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.1387_1392dup</td>
                  <td headers="hd_h_opa.T.opa1_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Ile463_Phe464dup</td>
                </tr>
                <tr>
                  <td headers="hd_h_opa.T.opa1_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.2708_2711delTTAG</td>
                  <td headers="hd_h_opa.T.opa1_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Val903GlyfsTer3</td>
                </tr>
                <tr>
                  <td headers="hd_h_opa.T.opa1_pathogenic_variants_discussed_1_1_1_1" valign="middle" align="left" scope="row" rowspan="1" colspan="1">c.2826delT</td>
                  <td headers="hd_h_opa.T.opa1_pathogenic_variants_discussed_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">p.Arg943GlufsTer25</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn>
                <p>Note on variant classification: Variants listed in the table have been provided by the authors. <italic toggle="yes">GeneReviews</italic> staff have not independently verified the classification of variants.</p>
              </fn>
              <fn>
                <p>Note on nomenclature: <italic toggle="yes">GeneReviews</italic> follows the standard naming conventions of the Human Genome Variation Society (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://varnomen.hgvs.org/">varnomen.hgvs.org</ext-link>). See <related-object link-type="booklink" source-id="gene" document-id="app3" document-type="appendix">Quick Reference</related-object> for an explanation of nomenclature.</p>
              </fn>
              <fn id="opa.TF.2.1">
                <label>1. </label>
                <p>Variant designation that does not conform to current naming conventions</p>
              </fn>
              <fn id="opa.TF.2.2">
                <label>2. </label>
                <p>In exon 5b of alternative transcript that encodes isoform 8 (<related-object source-id="gene" document-id="opa" object-id="opa.molgen.TA">Table A</related-object>, <bold>Gene</bold>)</p>
              </fn>
              <fn id="opa.TF.2.3">
                <label>3. </label>
                <p>Substitution in the antepenultimate nucleotide position of exon 9, which modifies the consensus sequence of the 5&#x02019; donor splice site of intron 9, resulting in an in-frame skipping of exon 9 [<xref ref-type="bibr" rid="opa.REF.baris.2003.656">Baris et al 2003</xref>]</p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
          <p><bold>Normal gene product.</bold> Dynamin-like 120-kd protein (OPA1), encoded by <italic toggle="yes">OPA1</italic>, is a mitochondrial dynamin-related GTP protein of 960 amino acids. This is the first dynamin-related protein found to be involved in human disease. The dynamin-like 120-kd protein comprises a highly basic amino-terminal that provides mitochondrial targeting sequence (MTS), a dynamin-GTPase domain, and a C-terminus of unknown function; the C-terminus differs from that of other dynamin family members in lacking a proline-rich region, a dynamin GTPase effector domain, and a pleckstrin homology domain; the C-terminus may therefore determine the specific functions of the dynamin-like 120-kd protein.</p>
          <p>OPA1 appears to exert its function in mitochondrial biogenesis and stabilization of mitochondrial membrane integrity. Downregulation of <italic toggle="yes">OPA1</italic> leads to fragmentation of the mitochondrial network and dissipation of the mitochondrial membrane potential with cytochrome c release and caspase-dependent apoptosis [<xref ref-type="bibr" rid="opa.REF.olichon.2003.7743">Olichon et al 2003</xref>]. Mitochondrial DNA (mtDNA) deletions have been identified in families with autosomal dominant optic atrophy who have complex multisystem involvement in addition to the optic neuropathy [<xref ref-type="bibr" rid="opa.REF.amatibonneau.2008.338">Amati-Bonneau et al 2008</xref>, <xref ref-type="bibr" rid="opa.REF.ferraris.2008.125">Ferraris et al 2008</xref>, <xref ref-type="bibr" rid="opa.REF.hudson.2008.329">Hudson et al 2008</xref>] suggesting a role of OPA1 in mtDNA maintenance.</p>
          <p><bold>Abnormal gene product.</bold> The functional consequences of pathogenic variants in <italic toggle="yes">OPA1</italic> are unknown. Since almost 50% of pathogenic variants predict protein truncation, dominant inheritance of the disease may result from haploinsufficiency of dynamin-like 120-kd protein. However, pathogenic missense variants can also cause disease by a dominant-negative mechanism.</p>
          <p>Interestingly, evidence for a dominant-negative mechanism has been reported in all the multi-systemic forms of the disease (ADOAD and &#x0201c;ADOA plus&#x0201d;). These disease forms have pathogenic missense variants affecting the GTPase domain [<xref ref-type="bibr" rid="opa.REF.amatibonneau.2008.338">Amati-Bonneau et al 2008</xref>]. In addition, one person with ADOA, who had biallelic pathogenic <italic toggle="yes">OPA1</italic> missense variants located in exon 8, was found to be severely affected by the disease [<xref ref-type="bibr" rid="opa.REF.pesch.2001.1359">Pesch et al 2001</xref>], whereas her heterozygous parents and sibs were less severely affected, suggesting a semi-dominant mode of inheritance in this family.</p>
        </sec>
      </sec>
      <sec id="opa.References">
        <title>References</title>
        <sec id="opa.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="opa.Literature_Cited.reflist0">
            <ref id="opa.REF.alward.2003.2">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Alward</surname>
                    <given-names>WL</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>The OPA1 gene and optic neuropathy.</article-title>
                <source>Br J Ophthalmol</source>
                <volume>87</volume>
                <fpage>2</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">12488251</pub-id>
              </element-citation>
            </ref>
            <ref id="opa.REF.amatibonneau.2005.958">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Amati-Bonneau</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guichet</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olichon</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chevrollier</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Viala</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miot</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ayuso</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Odent</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arrouet</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verny</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calmels</surname>
                    <given-names>MN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simard</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Belenguer</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Puel</surname>
                    <given-names>JL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamel</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malthiery</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonneau</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lenaers</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reynier</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>OPA1 R445H mutation in optic atrophy associated with sensorineural deafness.</article-title>
                <source>Ann Neurol</source>
                <volume>58</volume>
                <fpage>958</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">16240368</pub-id>
              </element-citation>
            </ref>
            <ref id="opa.REF.amatibonneau.2008.338">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Amati-Bonneau</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valentino</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reynier</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gallardo</surname>
                    <given-names>ME</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bornstein</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boissiere</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Campos</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rivera</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de la Aleja</surname>
                    <given-names>JG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carroccia</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iommarini</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Labauge</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Figarella-Branger</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marcorelles</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Furby</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Beauvais</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Letournel</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liguori</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>La Morgia</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Montagna</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liguori</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zanna</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rugolo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cossarizza</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wissinger</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verny</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schwarzenbacher</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arenas</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ayuso</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garesse</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lenaers</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonneau</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carelli</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>OPA1 mutations induce mitochondrial DNA instability and optic atrophy plus phenotypes.</article-title>
                <source>Brain</source>
                <volume>131</volume>
                <fpage>338</fpage>
                <lpage>51</lpage>
                <pub-id pub-id-type="pmid">18158317</pub-id>
              </element-citation>
            </ref>
            <ref id="opa.REF.andrews.1999.231">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Andrews</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Griffiths</surname>
                    <given-names>PG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turnbull</surname>
                    <given-names>DM</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Histochemical localisation of mitochondrial enzyme activity in human optic nerve and retina.</article-title>
                <source>Br J Ophthalmol</source>
                <volume>83</volume>
                <fpage>231</fpage>
                <lpage>5</lpage>
                <pub-id pub-id-type="pmid">10396204</pub-id>
              </element-citation>
            </ref>
            <ref id="opa.REF.baloh.2007.422">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Baloh</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schmidt</surname>
                    <given-names>RE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pestronk</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Milbrandt</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Altered axonal mitochondrial transport in the pathogenesis of Charcot-Marie-Tooth disease from mitofusin 2 mutations.</article-title>
                <source>J Neurosci</source>
                <volume>27</volume>
                <fpage>422</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">17215403</pub-id>
              </element-citation>
            </ref>
            <ref id="opa.REF.barbet.2005.e1">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Barbet</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hakiki</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Orssaud</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gerber</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perrault</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hanein</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ducroq</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dufier</surname>
                    <given-names>J-L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munnich</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaplan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rozet</surname>
                    <given-names>J-M</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>A third locus for dominant optic atrophy on chromosome 22q.</article-title>
                <source>J Med Genet</source>
                <volume>42</volume>
                <fpage>e1</fpage>
                <pub-id pub-id-type="pmid">15635063</pub-id>
              </element-citation>
            </ref>
            <ref id="opa.REF.baris.2003.656">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Baris</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Delettre</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amati-Bonneau</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Surget</surname>
                    <given-names>M-O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Charlin</surname>
                    <given-names>J-F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Catier</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dollfus</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jonveaux</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonneau</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ayuso</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maumenee</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lorenz</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mohammed</surname>
                    <given-names>SN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tourmen</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malthiery</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamel</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reynier</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Fourteen novel OPA1 mutations in dominant optic atrophy and de novo mutations in isolated cases of optic atrophy.</article-title>
                <source>Hum Mutat</source>
                <volume>21</volume>
                <fpage>656</fpage>
                <pub-id pub-id-type="pmid">14961560</pub-id>
              </element-citation>
            </ref>
            <ref id="opa.REF.bristow.2002.791">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bristow</surname>
                    <given-names>EA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Griffiths</surname>
                    <given-names>PG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andrews</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Johnson</surname>
                    <given-names>MA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turnbull</surname>
                    <given-names>DM</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>The distribution of mitochondrial activity in relation to optic nerve structure.</article-title>
                <source>Arch Ophthalmol</source>
                <volume>120</volume>
                <fpage>791</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">12049585</pub-id>
              </element-citation>
            </ref>
            <ref id="opa.REF.carelli.2007.a42">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Carelli</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schimpf</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valentino</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fuhrmann</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Papke</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schaich</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tippmann</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baumann</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barboni</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ghelli</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bucchi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lodi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barbiroli</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Liguori</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carroccia</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Villanova</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Montagna</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baruzzi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wissinger</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Dominant optic atrophy (DOA) and sensorineural hearing loss: clinical, biochemical, spectroscopic and molecular genetic study of a large Italian pedigree linked to a new locus an chromosome 16.</article-title>
                <source>Neurology</source>
                <volume>68</volume>
                <fpage>A42</fpage>
              </element-citation>
            </ref>
            <ref id="opa.REF.chen.2005.26185">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chomyn</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chan</surname>
                    <given-names>DC</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Disruption of fusion results in mitochondrial heterogeneity and dysfunction.</article-title>
                <source>J Biol Chem</source>
                <volume>280</volume>
                <fpage>26185</fpage>
                <lpage>92</lpage>
                <pub-id pub-id-type="pmid">15899901</pub-id>
              </element-citation>
            </ref>
            <ref id="opa.REF.cornille.2008.667">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cornille</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Milea</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amati-Bonneau</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Procaccio</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zazoun</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guillet</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>El Achouri</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Delettre</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gueguen</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Loiseau</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muller</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferr&#x000e9;</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chevrollier</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wallace</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonneau</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamel</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reynier</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lenaers</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Reversible optic neuropathy with OPA1 exon 5b mutation.</article-title>
                <source>Ann Neurol.</source>
                <volume>63</volume>
                <fpage>667</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">18360822</pub-id>
              </element-citation>
            </ref>
            <ref id="opa.REF.cryns.2003.275">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Cryns</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sivakumaran</surname>
                    <given-names>TA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van den Ouweland</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pennings</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cremers</surname>
                    <given-names>CW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flothmann</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Young</surname>
                    <given-names>TL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Smith</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lesperance</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Camp</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Mutational spectrum of the WFS1 gene in Wolfram syndrome, nonsyndromic hearing impairment, diabetes mellitus, and psychiatric disease.</article-title>
                <source>Hum Mutat</source>
                <volume>22</volume>
                <fpage>275</fpage>
                <lpage>87</lpage>
                <pub-id pub-id-type="pmid">12955714</pub-id>
              </element-citation>
            </ref>
            <ref id="opa.REF.delettre.2001.584">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Delettre</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Griffoin</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaplan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dollfus</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lorenz</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Faivre</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lenaers</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Belenguer</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamel</surname>
                    <given-names>CP</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Mutation spectrum and splicing variants in the OPA1 gene.</article-title>
                <source>Hum Genet</source>
                <volume>109</volume>
                <fpage>584</fpage>
                <lpage>91</lpage>
                <pub-id pub-id-type="pmid">11810270</pub-id>
              </element-citation>
            </ref>
            <ref id="opa.REF.eiberg.2006.435">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Eiberg</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hansen</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kjer</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hansen</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pedersen</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bille</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenberg</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tranebjaerg</surname>
                    <given-names>L</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Autosomal dominant optic atrophy associated with hearing impairment and impaired glucose regulation caused by a missense mutation in the WFS1 gene.</article-title>
                <source>J Med Genet</source>
                <volume>43</volume>
                <fpage>435</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">16648378</pub-id>
              </element-citation>
            </ref>
            <ref id="opa.REF.ferraris.2008.125">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ferraris</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clark</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garelli</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Davidzon</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moore</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kardon</surname>
                    <given-names>RH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bienstock</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Longley</surname>
                    <given-names>MJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mancuso</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rios</surname>
                    <given-names>PG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirano</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Copeland</surname>
                    <given-names>WC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>DiMauro</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Progressive external ophthalmoplegia and vision and hearing loss in a patient with mutations in POLG2 and OPA1.</article-title>
                <source>Arch Neurol</source>
                <volume>65</volume>
                <fpage>125</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">18195150</pub-id>
              </element-citation>
            </ref>
            <ref id="opa.REF.ferr_.2009.e692">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ferr&#x000e9;</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonneau</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Milea</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chevrollier</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verny</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dollfus</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ayuso</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Defoort</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vignal</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zanlonghi</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Charlin</surname>
                    <given-names>JF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaplan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Odent</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamel</surname>
                    <given-names>CP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Procaccio</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reynier</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amati-Bonneau</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Molecular screening of 980 cases of suspected hereditary optic neuropathy with a report on 77 novel OPA1 mutations.</article-title>
                <source>Hum Mutat.</source>
                <volume>30</volume>
                <fpage>E692</fpage>
                <lpage>705</lpage>
                <pub-id pub-id-type="pmid">19319978</pub-id>
              </element-citation>
            </ref>
            <ref id="opa.REF.ferr_.2015.20">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ferr&#x000e9;</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Caignard</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Milea</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leruez</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cassereau</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chevrollier</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amati-Bonneau</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verny</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonneau</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Procaccio</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reynier</surname>
                    <given-names>P</given-names>
                  </name>
                </person-group>
                <year>2015</year>
                <article-title>Improved locus-specific database for OPA1 mutations allows inclusion of advanced clinical data.</article-title>
                <source>Hum Mutat.</source>
                <volume>36</volume>
                <fpage>20</fpage>
                <lpage>25</lpage>
                <pub-id pub-id-type="pmid">25243597</pub-id>
              </element-citation>
            </ref>
            <ref id="opa.REF.gallus.2010.178">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gallus</surname>
                    <given-names>GN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cardaioli</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rufa</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Da Pozzo</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bianchi</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>D'Eramo</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Collura</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tumino</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pavone</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Federico</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Alu-element insertion in an OPA1 intron sequence associated with autosomal dominant optic atrophy.</article-title>
                <source>Mol Vis.</source>
                <volume>16</volume>
                <fpage>178</fpage>
                <lpage>83</lpage>
                <pub-id pub-id-type="pmid">20157369</pub-id>
              </element-citation>
            </ref>
            <ref id="opa.REF.hanein.2009.493">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hanein</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perrault</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roche</surname>
                    <given-names>O</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gerber</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khadom</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rio</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boddaert</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jean-Pierre</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brahimi</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Serre</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chretien</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Delphin</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fares-Taie</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lachheb</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rotig</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meire</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munnich</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dufier</surname>
                    <given-names>J-L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kaplan</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rozet</surname>
                    <given-names>J-M</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>TMEM126A, encoding a mitochondrial protein, is mutated in autosomal-recessive nonsyndromic optic atrophy.</article-title>
                <source>Am. J. Hum. Genet.</source>
                <volume>84</volume>
                <fpage>493</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">19327736</pub-id>
              </element-citation>
            </ref>
            <ref id="opa.REF.holder.1998.217">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Holder</surname>
                    <given-names>GE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Votruba</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carter</surname>
                    <given-names>AC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bhattacharya</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fitzke</surname>
                    <given-names>FW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moore</surname>
                    <given-names>AT</given-names>
                  </name>
                </person-group>
                <year>1998</year>
                <article-title>Electrophysiological findings in dominant optic atrophy (DOA) linking to the OPA1 locus on chromosome 3q 28-qter.</article-title>
                <source>Doc Ophthalmol</source>
                <volume>95</volume>
                <fpage>217</fpage>
                <lpage>28</lpage>
                <pub-id pub-id-type="pmid">10532406</pub-id>
              </element-citation>
            </ref>
            <ref id="opa.REF.hollenbeck.2005.331">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hollenbeck</surname>
                    <given-names>PJ</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Mitochondria and neurotransmission: evacuating the synapse.</article-title>
                <source>Neuron</source>
                <volume>47</volume>
                <fpage>331</fpage>
                <lpage>3</lpage>
                <pub-id pub-id-type="pmid">16055057</pub-id>
              </element-citation>
            </ref>
            <ref id="opa.REF.hollenbeck.2005.5411">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hollenbeck</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saxton</surname>
                    <given-names>WM</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>The axonal transport of mitochondria.</article-title>
                <source>J Cell Sci</source>
                <volume>118</volume>
                <fpage>5411</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">16306220</pub-id>
              </element-citation>
            </ref>
            <ref id="opa.REF.hudson.2008.329">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hudson</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amati-Bonneau</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blakely</surname>
                    <given-names>EL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stewart</surname>
                    <given-names>JD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>He</surname>
                    <given-names>LP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schaefer</surname>
                    <given-names>AM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Griffiths</surname>
                    <given-names>PG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ahlqvist</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Suomalainen</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reynier</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McFarland</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turnbull</surname>
                    <given-names>DM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chinnery</surname>
                    <given-names>PF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taylor</surname>
                    <given-names>RW</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>Mutation of OPA1 causes dominant optic atrophy with external ophthalmoplegia, ataxia, deafness and multiple mitochondrial DNA deletions: a novel disorder of mtDNA maintenance.</article-title>
                <source>Brain</source>
                <volume>131</volume>
                <fpage>329</fpage>
                <lpage>37</lpage>
                <pub-id pub-id-type="pmid">18065439</pub-id>
              </element-citation>
            </ref>
            <ref id="opa.REF.kamei.2005.4288">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kamei</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen-Kuo-Chang</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cazevieille</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lenaers</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olichon</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Belenguer</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Roussignol</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Renard</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eybalin</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Michelin</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Delettre</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brabet</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamel</surname>
                    <given-names>CP</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Expression of the Opa1 mitochondrial protein in retinal ganglion cells: its downregulation causes aggregation of the mitochondrial network.</article-title>
                <source>Invest Ophthalmol Vis Sci</source>
                <volume>46</volume>
                <fpage>4288</fpage>
                <lpage>94</lpage>
                <pub-id pub-id-type="pmid">16249510</pub-id>
              </element-citation>
            </ref>
            <ref id="opa.REF.kerrison.1999.805">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kerrison</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Arnould</surname>
                    <given-names>VJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferraz Sallum</surname>
                    <given-names>JM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vagefi</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barmada</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhu</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maumenee</surname>
                    <given-names>IH</given-names>
                  </name>
                </person-group>
                <year>1999</year>
                <article-title>Genetic heterogeneity of dominant optic atrophy, Kjer type: Identification of a second locus on chromosome 18q12.2-12.3.</article-title>
                <source>Arch Ophthalmol</source>
                <volume>117</volume>
                <fpage>805</fpage>
                <lpage>10</lpage>
                <pub-id pub-id-type="pmid">10369594</pub-id>
              </element-citation>
            </ref>
            <ref id="opa.REF.kjer.1996.3">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kjer</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eiberg</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kjer</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenberg</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>1996</year>
                <article-title>Dominant optic atrophy mapped to chromosome 3q region. II. Clinical and epidemiological aspects.</article-title>
                <source>Acta Ophthalmol Scand</source>
                <volume>74</volume>
                <fpage>3</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">8689476</pub-id>
              </element-citation>
            </ref>
            <ref id="opa.REF.leruez.2013.e236">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Leruez</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Milea</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Defoort-Dhellemmes</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Colin</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crochet</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Procaccio</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferr&#x000e9;</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lamblin</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Drouin</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vincent-Delorme</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lenaers</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamel</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blanchet</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Juul</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Larsen</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verny</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reynier</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amati-Bonneau</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonneau</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2013</year>
                <article-title>Sensorineural hearing loss in OPA1-linked disorders.</article-title>
                <source>Brain.</source>
                <volume>136</volume>
                <fpage>e236</fpage>
                <pub-id pub-id-type="pmid">23384603</pub-id>
              </element-citation>
            </ref>
            <ref id="opa.REF.li.2005.208">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kosmorsky</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Katz</surname>
                    <given-names>BJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ge</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Traboulsi</surname>
                    <given-names>EI</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Optic atrophy and sensorineural hearing loss in a family caused by an R445H OPA1 mutation.</article-title>
                <source>Am J Med Genet A</source>
                <volume>138A</volume>
                <fpage>208</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">16158427</pub-id>
              </element-citation>
            </ref>
            <ref id="opa.REF.li.2004.873">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Okamoto</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hayashi</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sheng</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>The importance of dendritic mitochondria in the morphogenesis and plasticity of spines and synapses.</article-title>
                <source>Cell</source>
                <volume>119</volume>
                <fpage>873</fpage>
                <lpage>87</lpage>
                <pub-id pub-id-type="pmid">15607982</pub-id>
              </element-citation>
            </ref>
            <ref id="opa.REF.lodi.2004.719">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lodi</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tonon</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valentino</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Iotti</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Clementi</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malucelli</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barboni</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Longanesi</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schimpf</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wissinger</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baruzzi</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barbiroli</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carelli</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Deficit of in vivo mitochondrial ATP production in OPA1-related dominant optic atrophy.</article-title>
                <source>Ann Neurol</source>
                <volume>56</volume>
                <fpage>719</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">15505825</pub-id>
              </element-citation>
            </ref>
            <ref id="opa.REF.marchbank.2002.e47">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Marchbank</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Craig</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leek</surname>
                    <given-names>JP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toohey</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Churchill</surname>
                    <given-names>AJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Markham</surname>
                    <given-names>AF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mackey</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Toomes</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inglehearn</surname>
                    <given-names>CF</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>Deletion of the OPA1 gene in a dominant optic atrophy family: evidence that haploinsufficiency is the cause of disease.</article-title>
                <source>J Med Genet</source>
                <volume>39</volume>
                <fpage>e47</fpage>
                <pub-id pub-id-type="pmid">12161614</pub-id>
              </element-citation>
            </ref>
            <ref id="opa.REF.meire.1985.91">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Meire</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Laey</surname>
                    <given-names>JJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Bie</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Staey</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Matton</surname>
                    <given-names>MT</given-names>
                  </name>
                </person-group>
                <year>1985</year>
                <article-title>Dominant optic nerve atrophy with progressive hearing loss and chronic progressive external ophthalmoplegia (CPEO).</article-title>
                <source>Ophthalmic Paediatr Genet</source>
                <volume>5</volume>
                <fpage>91</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">4058877</pub-id>
              </element-citation>
            </ref>
            <ref id="opa.REF.nakamura.2006.483">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Nakamura</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ueno</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Asaoka</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hirai</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hotta</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Miyake</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Terasaki</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Novel mutations in the OPA1 gene and associated clinical features in Japanese patients with optic atrophy.</article-title>
                <source>Ophthalmology</source>
                <volume>113</volume>
                <fpage>483</fpage>
                <lpage>8.e1</lpage>
                <pub-id pub-id-type="pmid">16513463</pub-id>
              </element-citation>
            </ref>
            <ref id="opa.REF.olichon.2003.7743">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Olichon</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baricault</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gas</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guillou</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Valette</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Belenguer</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lenaers</surname>
                    <given-names>G</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Loss of OPA1 perturbates the mitochondrial inner membrane structure and integrity, leading to cytochrome c release and apoptosis.</article-title>
                <source>J Biol Chem</source>
                <volume>278</volume>
                <fpage>7743</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">12509422</pub-id>
              </element-citation>
            </ref>
            <ref id="opa.REF.payne.2004.749">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Payne</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yang</surname>
                    <given-names>Z</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Katz</surname>
                    <given-names>BJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Warner</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Weight</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhao</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pearson</surname>
                    <given-names>ED</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Treft</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hillman</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kennedy</surname>
                    <given-names>RJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Meire</surname>
                    <given-names>FM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zhang</surname>
                    <given-names>K</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Dominant optic atrophy, sensorineural hearing loss, ptosis, and ophthalmoplegia: a syndrome caused by a missense mutation in OPA1.</article-title>
                <source>Am J Ophthalmol</source>
                <volume>138</volume>
                <fpage>749</fpage>
                <lpage>55</lpage>
                <pub-id pub-id-type="pmid">15531309</pub-id>
              </element-citation>
            </ref>
            <ref id="opa.REF.pesch.2001.1359">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Pesch</surname>
                    <given-names>UE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Leo-Kottler</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mayer</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jurklies</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kellner</surname>
                    <given-names>U</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Apfelstedt-Sylla</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zrenner</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alexander</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wissinger</surname>
                    <given-names>B</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>OPA1 mutations in patients with autosomal dominant optic atrophy and evidence for semi-dominant inheritance</article-title>
                <source>Hum Mol Genet</source>
                <volume>10</volume>
                <fpage>1359</fpage>
                <lpage>68</lpage>
                <pub-id pub-id-type="pmid">11440988</pub-id>
              </element-citation>
            </ref>
            <ref id="opa.REF.puomila.2005.337">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Puomila</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Huoponen</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mantyjarvi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamalainen</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Paananen</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sankila</surname>
                    <given-names>EM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Savontaus</surname>
                    <given-names>ML</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Somer</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Nikoskelainen</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Dominant optic atrophy: correlation between clinical and molecular genetic studies.</article-title>
                <source>Acta Ophthalmol Scand</source>
                <volume>83</volume>
                <fpage>337</fpage>
                <lpage>46</lpage>
                <pub-id pub-id-type="pmid">15948788</pub-id>
              </element-citation>
            </ref>
            <ref id="opa.REF.reynier.2004.e110">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Reynier</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amati-Bonneau</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verny</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olichon</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Simard</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guichet</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonnemains</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malecaze</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malinge</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pelletier</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Calvas</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dollfus</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Belenguer</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Malthi&#x000e8;ry</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lenaers</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bonneau</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>OPA3 gene mutations responsible for autosomal dominant optic atrophy and cataract.</article-title>
                <source>J Med Genet</source>
                <volume>41</volume>
                <fpage>e110</fpage>
                <pub-id pub-id-type="pmid">15342707</pub-id>
              </element-citation>
            </ref>
            <ref id="opa.REF.shimizu.2003.256">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Shimizu</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mori</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kishi</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sugata</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsuda</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kubota</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>A novel mutation in the OPA1 gene in a Japanese patient with optic atrophy.</article-title>
                <source>Am J Ophthalmol</source>
                <volume>135</volume>
                <fpage>256</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">12566046</pub-id>
              </element-citation>
            </ref>
            <ref id="opa.REF.thiselton.2002.1715">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Thiselton</surname>
                    <given-names>DL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Alexander</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Taanman</surname>
                    <given-names>JW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Brooks</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rosenberg</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Eiberg</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Andreasson</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Regemorter</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Munier</surname>
                    <given-names>FL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moore</surname>
                    <given-names>AT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bhattacharya</surname>
                    <given-names>SS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Votruba</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>A comprehensive survey of mutations in the OPA1 gene in patients with autosomal dominant optic atrophy.</article-title>
                <source>Invest Ophthalmol Vis Sci</source>
                <volume>43</volume>
                <fpage>1715</fpage>
                <lpage>24</lpage>
                <pub-id pub-id-type="pmid">12036970</pub-id>
              </element-citation>
            </ref>
            <ref id="opa.REF.toomes.2001.1369">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Toomes</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Marchbank</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mackey</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Craig</surname>
                    <given-names>JE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Newbury-Ecob</surname>
                    <given-names>RA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bennett</surname>
                    <given-names>CP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vize</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Desai</surname>
                    <given-names>SP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Black</surname>
                    <given-names>GC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patel</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teimory</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Markham</surname>
                    <given-names>AF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Inglehearn</surname>
                    <given-names>CF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Churchill</surname>
                    <given-names>AJ</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Spectrum, frequency and penetrance of OPA1 mutations in dominant optic atrophy.</article-title>
                <source>Hum Mol Genet</source>
                <volume>10</volume>
                <fpage>1369</fpage>
                <lpage>78</lpage>
                <pub-id pub-id-type="pmid">11440989</pub-id>
              </element-citation>
            </ref>
            <ref id="opa.REF.treft.1984.908">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Treft</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sanborn</surname>
                    <given-names>GE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Carey</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Swartz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Crisp</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wester</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Creel</surname>
                    <given-names>D</given-names>
                  </name>
                </person-group>
                <year>1984</year>
                <article-title>Dominant optic atrophy, deafness, ptosis, ophthalmoplegia, dystaxia, and myopathy. A new syndrome.</article-title>
                <source>Ophthalmology</source>
                <volume>91</volume>
                <fpage>908</fpage>
                <lpage>15</lpage>
                <pub-id pub-id-type="pmid">6493699</pub-id>
              </element-citation>
            </ref>
            <ref id="opa.REF.voo.2003.670">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Voo</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Allf</surname>
                    <given-names>BE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Udar</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Silva-Garcia</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vance</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Small</surname>
                    <given-names>KW</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Hereditary motor and sensory neuropathy type VI with optic atrophy.</article-title>
                <source>Am J Ophthalmol</source>
                <volume>136</volume>
                <fpage>670</fpage>
                <lpage>7</lpage>
                <pub-id pub-id-type="pmid">14516807</pub-id>
              </element-citation>
            </ref>
            <ref id="opa.REF.votruba.2003.48">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Votruba</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Thiselton</surname>
                    <given-names>D</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bhattacharya</surname>
                    <given-names>SS</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Optic disc morphology of patients with OPA1 autosomal dominant optic atrophy.</article-title>
                <source>Br J Ophthalmol</source>
                <volume>87</volume>
                <fpage>48</fpage>
                <lpage>53</lpage>
                <pub-id pub-id-type="pmid">12488262</pub-id>
              </element-citation>
            </ref>
            <ref id="opa.REF.wang.2003.2">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dong</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cull</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fortune</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cioffi</surname>
                    <given-names>GA</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Varicosities of intraretinal ganglion cell axons in human and nonhuman primates.</article-title>
                <source>Invest Ophthalmol Vis Sci</source>
                <volume>44</volume>
                <fpage>2</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">12506048</pub-id>
              </element-citation>
            </ref>
            <ref id="opa.REF.z_chner.2006.276">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Z&#x000fc;chner</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Jonghe</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jordanova</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Claeys</surname>
                    <given-names>KG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Guergueltcheva</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cherninkova</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamilton</surname>
                    <given-names>SR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van Stavern</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Krajewski</surname>
                    <given-names>KM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stajich</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tournev</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Verhoeven</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Langerhorst</surname>
                    <given-names>CT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Visser</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Baas</surname>
                    <given-names>F</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bird</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Timmerman</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shy</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vance</surname>
                    <given-names>JM</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Axonal neuropathy with optic atrophy is caused by mutations in mitofusin 2.</article-title>
                <source>Ann Neurol</source>
                <volume>59</volume>
                <fpage>276</fpage>
                <lpage>81</lpage>
                <pub-id pub-id-type="pmid">16437557</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="opa.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="opa.Suggested_Reading.reflist0">
            <ref id="opa.REF.carelli.2004.53">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Carelli</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ross-Cisneros</surname>
                    <given-names>FN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sadun</surname>
                    <given-names>AA</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Mitochondrial dysfunction as a cause of optic neuropathies.</article-title>
                <source>Prog Retin Eye Res</source>
                <volume>23</volume>
                <fpage>53</fpage>
                <lpage>89</lpage>
                <pub-id pub-id-type="pmid">14766317</pub-id>
              </element-citation>
            </ref>
            <ref id="opa.REF.chinnery.2005.940">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Chinnery</surname>
                    <given-names>PF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Griffiths</surname>
                    <given-names>PG</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Optic mitochondriopathies.</article-title>
                <source>Neurology</source>
                <volume>64</volume>
                <fpage>940</fpage>
                <lpage>1</lpage>
                <pub-id pub-id-type="pmid">15781804</pub-id>
              </element-citation>
            </ref>
            <ref id="opa.REF.delettre.2002.97">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Delettre</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lenaers</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Pelloquin</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Belenguer</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hamel</surname>
                    <given-names>CP</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>OPA1 (Kjer type) dominant optic atrophy: a novel mitochondrial disease.</article-title>
                <source>Mol Genet Metab</source>
                <volume>75</volume>
                <fpage>97</fpage>
                <lpage>107</lpage>
                <pub-id pub-id-type="pmid">11855928</pub-id>
              </element-citation>
            </ref>
            <ref id="opa.REF.howell.2003.94">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Howell</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>LHON and other optic nerve atrophies: the mitochondrial connection.</article-title>
                <source>Dev Ophthalmol</source>
                <volume>37</volume>
                <fpage>94</fpage>
                <lpage>108</lpage>
                <pub-id pub-id-type="pmid">12876832</pub-id>
              </element-citation>
            </ref>
            <ref id="opa.REF.newman.2005.517">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Newman</surname>
                    <given-names>NJ</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Hereditary optic neuropathies: from the mitochondria to the optic nerve.</article-title>
                <source>Am J Ophthalmol</source>
                <volume>140</volume>
                <fpage>517</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">16083845</pub-id>
              </element-citation>
            </ref>
            <ref id="opa.REF.newman.2004.1144">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Newman</surname>
                    <given-names>NJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Biousse</surname>
                    <given-names>V</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Hereditary optic neuropathies.</article-title>
                <source>Eye</source>
                <volume>18</volume>
                <fpage>1144</fpage>
                <lpage>60</lpage>
                <pub-id pub-id-type="pmid">15534600</pub-id>
              </element-citation>
            </ref>
            <ref id="opa.REF.votruba.2004.1126">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Votruba</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2004</year>
                <article-title>Molecular genetic basis of primary inherited optic neuropathies.</article-title>
                <source>Eye</source>
                <volume>18</volume>
                <fpage>1126</fpage>
                <lpage>32</lpage>
                <pub-id pub-id-type="pmid">15534598</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="opa.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="opa.Author_Notes">
          <title>Author Notes</title>
          <p><bold>Institute for Neurosciences of Montpellier</bold>Web: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://www.inmfrance.com/us/">Institut des Neurosciences de Montpellier</ext-link></p>
          <p><bold>MAOLYA Center (National Reference Center for Genetic Sensory Disorders)</bold>Ophthalmology Service, 1<sup>er</sup> floorH&#x000f4;pital Gui de Chauliac80, Avenue Augustin Fliche34 295 Montpellier Cedex 5, FrancePhone: (33/0) 467&#x000a0;330 278 / (33/0) 467&#x000a0;330 279Email: <email xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="msg@chu-montpellier.fr">msg@chu-montpellier.fr</email>Web: <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://wwwold.chu-montpellier.fr/maolya/">wwwold.chu-montpellier.fr/maolya</ext-link></p>
        </sec>
        <sec id="opa.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>12 November 2015 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>20 July 2010 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>24 March 2009 (cd) Revision: targeted mutation analysis for Danish founder mutation available clinically</p>
            </list-item>
            <list-item>
              <p>7 August 2008 (cd) Revision: deletion/duplication analysis available clinically</p>
            </list-item>
            <list-item>
              <p>13 July 2007 (me) Review posted to live Web site</p>
            </list-item>
            <list-item>
              <p>23 October 2006 (cdc) Original submission</p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
